US Drug Recall Register
Class II · Moderate risk Terminated Initiated Nov 30, 2012 (14 years ago)

VERSAPHARM Ethambutol Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Discoloration: Ethambutol Tablets USP 400 mg have tablets cores that may be discolored.

What was recalled

VERSAPHARM Ethambutol Tablets, USP,400 mg, Rx Only a)60 tablets, NDC 61748-014-06, b)90 tablets, NDC 61748-014-09, c)100 tablets, NDC 61748-014-01, d)1000 tablets, NDC 61748-014-10, e) blister pack (10s) 61748-014-11 Manufactured for: VersaPharm Incorporated Marietta, GA 30062-2260, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.

Recalling firm
West-ward Pharmaceutical Corp.
NDC code
61748-014-06
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-189-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ethambutol recalls

See all
Class II · Moderate risk Terminated

Ethambutol HCl active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-660-2015
Class II · Moderate risk Terminated

Teva Ethambutol Hydrochloride Tablets

Reason CGMP Deviations: Ethambutol Hydrochloride Tablets, USP, 400 mg were manufactured using unapproved material: the incorrect gelatin excipient than specified in the product formulation.

Teva Pharmaceuticals USA NDC 0555-0923-02 D-1092-2014
Class II · Moderate risk Terminated

VersaPharm Incorporated

Reason Discoloration: Ethambutol HCl Tablets 400 mg is being recalled due to a Out of Specification result for description testing for a surface defect of ink.

West-Ward Pharmaceutical Corp. NDC 61748-014-06 D-839-2013
Class II · Moderate risk Terminated

Ethambutol Hydrochloride Tablets

Reason Subpotent Drug: Out Of Specification results for assay at the stability time-point of 24 months.

West-ward Pharmaceutical Corp. NDC 61748-011-01 D-242-2013